In silico and in vivo evaluation of bacteriophage φEF24C, a candidate for treatment of Enterococcus faecalis infections

Applied and Environmental Microbiology

Volumn 74, Issue 13, 2008, Pages 4149-4163

  Uchiyama, Jumpei ^a   Rashel, Mohammad ^a   Takemura, Iyo ^a   Wakiguchi, Hiroshi ^a   Matsuzaki, Shigenobu ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; BIOINFORMATICS; CONCENTRATION (PROCESS); FORECASTING; HEALTH; INTEGRAL EQUATIONS; PROTEINS; TRANSCRIPTION; VIRUSES;

ALTERNATIVE THERAPY; AMERICAN SOCIETY; ENTEROCOCCUS FAECALIS; IN VIVO EVALUATION; IN-SILICO; IN-VIVO; INFECTIOUS DISEASES; LISTERIA; LOW CONCENTRATIONS; MOUSE MODELS; OPEN READING FRAME (ORF); PHAGE THERAPY; PUBLIC DATABASES; TRNA GENES; VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE);

SENSITIVITY ANALYSIS;

TRANSFER RNA;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIOPHAGE; BIOINFORMATICS; DATABASE; DISEASE TREATMENT; FECAL COLIFORM; GENETIC ANALYSIS; GENOME; INFECTIOUS DISEASE; PROTEIN; RNA; RODENT; VIRULENCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE PHIEF24C; BAGG ALBINO MOUSE; BIOINFORMATICS; COMPUTER ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; GENE REPLICATION; GENETIC TRANSCRIPTION; HOSPITAL INFECTION; IN VIVO STUDY; LISTERIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; RNA GENE; SEPSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS GENOME;

ANIMALS; BACTERIOPHAGES; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; FEMALE; GENOME, VIRAL; GRAM-POSITIVE BACTERIAL INFECTIONS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEPSIS; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

ENTEROCOCCUS FAECALIS; LISTERIA;

EID: 46949111817     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.02371-07     Document Type: Article

References (50)

1. Bamford, D. H., J. M. Grimes, and D. I. Stuart. 2005. What does structure tell us about virus evolution? Curr. Opin. Struct. Biol. 15:655-663.
2. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
3. Besemer, J., and M. Borodovsky. 2005. GeneMark: web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res. 33:e451-e454.
4. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
5. Bonten, M. J., R. Willems, and R. A. Weinstein. 2001. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect. Dis. 1:314-325.
6. Botstein, D. 1980. A theory of modular evolution for bacteriophages. Ann. N. Y. Acad. Sci. 354:484-490.
7. Bradley, J. S., R. Guidos, S. Baragona, J. G. Bartlett, E. Rubinstein, G. G. Zhanel, M. D. Tino, D. L. Pompliano, F. Tally, P. Tipirneni, G. S. Tillotson, J. H. Powers, and G. S. Tillotson. 2007. Anti-infective research and development-problems, challenges, and solutions. Lancet Infect. Dis. 7:68-78.
8. Carlton, R. M., W. H. Noordman, B. Biswas, E. D. de Meester, and M. J. Loessner. 2005. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul. Toxicol. Pharmacol. 43:301-312.
9. Cetinkaya, Y., P. Falk, and C. G. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
10. Chibani-Chennoufi, S., M. L. Dillmann, L. Marvin-Guy, S. Rami-Shojaei, and H. Brüssow. 2004. Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J. Bacteriol. 186: 7069-7083.
11. Comeau, A. M., C. Bertrand, A. Letarov, F. Tétart, and H. M. Krisch. 2007. Modular architecture of the T4 phage superfamily: a conserved core genome and a plastic periphery. Virology 362:384-396.
12. Delcher, A. L., K. A. Bratke, E. C. Powers, and S. L. Salzberg. 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23:673-679.
13. Deshpande, A. M., and C. S. Newlon. 1996. DNA replication fork pause sites dependent on transcription. Science 272:1030-1033.
14. Deshpande, L. M., T. R. Fritsche, G. J. Moet, D. J. Biedenbach, and R. N. Jones. 2007. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 58:163-170.
15. Fischetti, V. A., D. Nelson, and R. Schuch. 2006. Reinventing phage therapy: are the parts greater than the sum? Nat. Biotechnol. 24:1508-1511.
16. Fraser, J. S., K. L. Maxwell, and A. R. Davidson. 2007. Immunoglobulin-like domains on bacteriophage: weapons of modest damage? Curr. Opin. Microbiol. 10:382-387.
17. Fraser, J. S., Z. Yu, K. L. Maxwell, and A. R. Davidson. 2006. Ig-like domains on bacteriophages: a tale of promiscuity and deceit. J. Mol. Biol. 359:496-507.
18. Freeman, M. J., N. T. Plasterer, F. T. Smith, and C. S. Mohr. 1998. Patterns of genome organization in bacteria. Science 279:1827.
19. Fujita, N. 2005. Vancomycin-resistant enterococci (VRE)-for VRE endemics in Japan. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 16:1-16. (In Japanese.)
20. Gill, J. J., M. E. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50:2912-2918.
21. Gomi, H. 2007. Sepsis. Nippon Rinsho 65(Suppl. 3):613-616. (In Japanese.)
22. Greenberg, R. G., P. He, J. Hilfinger, and M. J. Tseng. 1994. Deoxyribonucleoside triphosphate synthesis and phage T4 DNA replication, p. 14-27. In J. D. Karam, J. W. Drake, and K. N. Kreuzer (ed.), Molecular biology of bacteriophage T4. ASM Press, Washington, DC.
23. Grigoriev, A. 1998. Analyzing genomes with cumulative skew diagrams. Nucleic Acids Res. 26:2286-2290.
24. Grigoriev, A. 1999. Strand-specific compositional asymmetries in double-stranded DNA viruses. Virus Res. 60:1-19.
25. Guttman, B., R. Raya, and E. Kutter. 2005. Basic phage biology, p. 29-66. In E. Kutter and A. Sulakvelidze (ed.), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.
26. Hambly, E., F. Tétart, C. Desplats, W. H. Wilson, H. M. Krisch, and N. H. Mann. 2001. A conserved genetic module that encodes the major virion components in both the coliphage T4 and the marine cyanophage S-PM2. Proc. Natl. Acad. Sci. USA 98:11411-11416.
27. Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 30:118-128.
28. Hendrix, R. W., and S. R. Casjens. 2005. Myoviridae, p. 43-55. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy. Eighth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.
29. Kaspárek, P., R. Pantůcek, J. Kahánková, V. Růzicková, and J. Doskar. 2007. Genome rearrangements in host-range mutants of the polyvalent staphylococcal bacteriophage 812. Folia Microbiol. (Praha) 52:331-338.
30. Kayser, F. H. 2003. Safety aspects of enterococci from the medical point of view. Int. J. Food Microbiol. 88:255-262.
31. Krogh, A., B. Larsson, G. von Heijne, and E. L. Sonnhammer. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580.
32. Kwan, T., J. Liu, M. DuBow, P. Gros, and J. Pelletier. 2005. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc. Natl. Acad. Sci. USA 102:5174-5179.
33. Lei, H. Y., S. H. Lee, and S. H. Leir. 1996. Antigen-induced anaphylactic death in mice. Int. Arch. Allergy Immunol. 109:407-412.
34. Lowe, T. M., and S. R. Eddy. 1997. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25:955-964.
35. Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujimoto, M. D. Nasimuzzaman, H. Wakiguchi, S. Sugihara, T. Sugiura, S. Koda, A. Muraoka, and S. Imai. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage φMR11. J. Infect. Dis. 187:613-624.
36. Merril, R. C., D. Scholl, and S. Adhya. 2006. Phage therapy, p. 725-741. In R. Calender and T. S. Abedon (ed.), The bacteriophages, 2nd ed. Oxford University Press, New York, NY.
37. Miller, E. S., E. Kutter, G. Mosig, F. Arisaka, T. Kunisawa, and W. Ruger. 2003. Bacteriophage T4 genome. Microbiol. Mol. Biol. Rev. 67:86-156.
38. Mulder, N. J., R. Apweiler, T. K. Attwood, A. Bairoch, A. Bateman, D. Binns, P. Bork, V. Buillard, L. Cerutti, R. Copley, E. Courcelle, U. Das, L. Daugherty, M. Dibley, R. Finn, W. Fleischmann, J. Gough, D. Haft, N. Hulo, S. Hunter, D. Kahn, A. Kanapin, A. Kejariwal, A. Labarga, P. S. Langendijk- Genevaux, D. Lonsdale, R. Lopez, I. Letunic, M. Madera, J. Maslen, C. McAnulla, J. McDowall, J. Mistry, A. Mitchell, A. N. Nikolskaya, S. Orchard, C. Orengo, R. Petryszak, J. D. Selengut, C. J. Sigrist, P. D. Thomas, F. Valentin, D. Wilson, C. H. Wu, and C. Yeats. 2007. New developments in the InterPro database. Nucleic Acids Res. 35:e224-e228.
39. O'Flaherty, S., A. Coffey, R. Edwards, W. Meaney, G. F. Fitzgerald, and R. P. Ross. 2004. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J. Bacteriol. 186:2862-2871.
40. O'Flaherty, S., R. P. Ross, W. Meaney, G. F. Fitzgerald, M. F. Elbreki, and A. Coffey. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl. Environ. Microbiol. 71:1836-1842.
41. Okajima, K. 2007. Multiple organ failure associated with severe infection-the molecular mechanism(s) and new therapeutic strategies. Nippon Rinsho 65(Suppl. 3):619-626. (In Japanese.)
42. Petty, N. K., T. J. Evans, P. C. Fineran, and G. P. Salmond. 2007. Biotechnological exploitation of bacteriophage research. Trends Biotechnol. 25: 7-15.
43. Sulakvelidze, A., and E. Kutter. 2005. Bacteriophage therapy in humans, p. 381-436. In E. Kutter and A. Sulakevelidze (ed.), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.
44. Tamames, J. 2001. Evolution of gene order conservation in prokaryotes. Genome Biol. 2:research0020.1-research0020.11. doi:10.1186/gb-2001-2-6-research0020.
45. Tang, S. L., S. Nuttall, K. Ngui, C. Fisher, P. Lopez, and M. Dyall-Smith. 2002. HF2: a double-stranded DNA tailed haloarchaeal virus with a mosaic genome. Mol. Microbiol. 44:283-296.
46. Tyson, G. W., J. Chapman, P. Hugenholtz, E. E. Allen, R. J. Ram, P. M. Richardson, V. V. Solovyev, E. M. Rubin, D. S. Rokhsar, and J. F. Banfield. 2004. Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 428:37-43.
47. Uchiyama, J., M. Rashel, Y. Maeda, I. Takemura, S. Sugihara, K. Akechi, A. Muraoka, H. Wakiguchi, and S. Matsuzaki. 2008. Isolation and characterization of a novel Enterococcus faecalis bacteriophage φEF24C as a candidate therapeutic. FEMS Microbiol. Lett. 278:200-206.
48. Vinodkumar, C. S., Y. F. Neelagund, and S. Kalsurmath. 2005. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae. J. Commun. Dis. 37:18-29.
49. Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, D. Tao, L. Ding, E. Reed, J. Gong, Q. Q. Li, and J. Hu. 2006. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia. Int. J. Mol. Med. 17:347-355.
50. Watanabe, R., T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y. Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, and K. Yamaguchi. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51:446-452.